CORRECTION article

Front. Immunol., 01 February 2024

Sec. Vaccines and Molecular Therapeutics

Volume 15 - 2024 | https://doi.org/10.3389/fimmu.2024.1376059

Corrigendum: Enhanced immunogenicity and protective efficacy in mice following a Zika DNA vaccine designed by modulation of membrane-anchoring regions and its association to adjuvants

  • 1. Laboratory of Dermatology and Immunodeficiencies, LIM-56, Department of Dermatology, Tropical Medicine Institute of São Paulo, University of São Paulo Medical School, São Paulo, Brazil

  • 2. Department of Immunology, Institute of Biomedical Sciences, University of São Paulo, São Paulo, Brazil

  • 3. Department of Virology, Aggeu Magalhães Institute, Oswaldo Cruz Foundation, Recife, Brazil

Article metrics

View details

1

Citations

852

Views

382

Downloads

In the published article, there was an error regarding the author list for Maria Notomi Sato and Isabelle Freire Tabosa Viana. As well as having being the corresponding author, they should also have “These authors share senior authorship.”.

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Statements

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Summary

Keywords

DNA vaccine, Zika virus, envelope protein, membrane-anchoring regions, adjuvants, protection, immunogenicity

Citation

Teixeira FME, Oliveira LM, Branco ACCC, Alberca R, Sousa ESA, Leite BHS, Adan WCS, Duarte AJS, Lins RD, Sato M and Viana IFT (2024) Corrigendum: Enhanced immunogenicity and protective efficacy in mice following a Zika DNA vaccine designed by modulation of membrane-anchoring regions and its association to adjuvants. Front. Immunol. 15:1376059. doi: 10.3389/fimmu.2024.1376059

Received

24 January 2024

Accepted

25 January 2024

Published

01 February 2024

Approved by

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Volume

15 - 2024

Updates

Copyright

*Correspondence: Isabelle Freire Tabosa Viana, ; Maria Notomi Sato,

†These authors share senior authorship

Disclaimer

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Outline

Cite article

Copy to clipboard


Export citation file


Share article

Article metrics